Shares of FibroGen (FGEN) jumped by a staggering 20.86% in 7 days from $20.81 to $25.15 at 17:11 EST on Thursday, after four successive sessions in a row of gains. NASDAQ Composite (FGEN) is jumping 0.78% to $14,020.33, following the last session’s downward trend,
FibroGen’s last close was $24.56, 57.07% below its 52-week high of $57.21.
Today’s last reported volume for FibroGen is 594327 which is 61.14% below its average volume of 1529389.
The company’s growth estimates for the ongoing quarter is 52.6% and a drop 45.7% for the next.
Year-on-year quarterly revenue growth grew by 715.1%, now sitting on 176.32M for the twelve trailing months.
FibroGen’s last week, last month’s, and last quarter’s current volatility was a negative 1.07%, a positive 0.25%, and a positive 3.70%, respectively.
FibroGen’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.29% (last week), 2.31% (last month), and 3.70% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
FibroGen’s stock is considered to be oversold (<=20).
FibroGen’s Stock Yearly Top and Bottom Value
FibroGen’s stock is valued at $25.15 at 17:11 EST, way below its 52-week high of $57.21 and way above its 52-week low of $18.12.
FibroGen’s Moving Average
FibroGen’s value is way higher than its 50-day moving average of $21.36 and way below its 200-day moving average of $34.93.
More news about FibroGen (FGEN).